CYFIP2 Polyclonal Antibody

CYFIP2 belongs to the CYFIP family and is involved in T-cell adhesion and p53-dependent induction of apoptosis. CYFIP2 mRNA is ubiquitously expressed and particularly abundant in the central nervous system. Recently, CYFIP2 was regarded as one of the ALS potential biomarkes in non-neural tissues from amyotrophic lateral sclerosis (ALS) patients that may have direct diagnostic and therapeutic implications to the disease.

The CYFIP2 Polyclonal Antibody is a highly specific and sensitive antibody designed for the detection of CYFIP2 protein in various biological samples. This antibody is produced by immunizing rabbits with a synthetic peptide corresponding to the C-terminal region of human CYFIP2 protein. The resulting polyclonal antibody has been purified using protein A affinity chromatography and validated for its specificity and sensitivity through various assays.

The CYFIP2 protein is a member of the CYFIP family of proteins, which are involved in the regulation of actin cytoskeleton dynamics and synaptic function. CYFIP2 has been implicated in various cellular processes, including cell migration, axon guidance, and dendritic spine formation. Dysregulation of CYFIP2 expression has been associated with several neurological disorders, including autism spectrum disorder and schizophrenia.

The CYFIP2 Polyclonal Antibody is suitable for use in various applications, including Western blotting, immunohistochemistry, and immunofluorescence. This antibody has been shown to specifically detect CYFIP2 protein in human, mouse, and rat tissues. The high specificity and sensitivity of this antibody make it an ideal tool for studying the role of CYFIP2 in various biological processes and diseases.

In summary, the CYFIP2 Polyclonal Antibody is a reliable and effective tool for the detection of CYFIP2 protein in various biological samples. Its high specificity and sensitivity make it an ideal choice for researchers studying the role of CYFIP2 in various cellular processes and diseases.